(最終更新日:2025-01-14 12:09:14)
  ホリタニ ケイタ   HORITANI KEITA
  堀谷 啓太
   所属   関西医科大学  内科学第二講座
   職種   助教
■ 学術雑誌掲載論文
1. 原著(症例報告除く)  Influence of Postprandial Hyperglycemia and Hypertriglyceridemia: A Focus on Endothelial Progenitor Cells and Bone Marrow Stem/Progenitor Cell Senescence 2024/09
2. 原著(症例報告除く)  Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure 2024/03
3. 原著(症例報告除く)  Tet2-mediated clonal hematopoiesis modestly improves neurological deficits and is associated with inflammation resolution in the subacute phase of experimental stroke. 2024
4. 原著(症例報告除く)  Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction 2023/10
5. 原著(症例報告除く)  Wnt5a-YAP signaling axis mediates mechanotransduction in cardiac myocytes and contributes to contractile dysfunction induced by pressure overload 2023/06
全件表示(9件)
■ 学会発表
1. エンパグリフロジンは線維芽細胞におけるCCL2発現を抑制することでCCR2+マクロファージの動員を阻害し、心不全の進行を遅らせる。 (ポスター掲示,一般) 2024/12/07
2. 心原性ショックに至ったたこつぼ型心筋症様の1例 (口頭,一般) 2024/12/07
3. Empagliflozin Inhibits the Mobilization of CCR2+ Monocyte-Derived Macrophages by Reducing CCL2 Expression in Fibroblasts and Slows the Progression of Heart Failure After Pressure Overload. (ポスター掲示,一般) 2024/11/18
4. Empagliflozin's Cardioprotective Role Through Modulation of CCL2 Expression in Cardiac Fibroblasts, Attenuation of Inflammation, and Mitigation of Heart Failure Progression. (口頭,一般) 2024/05/09
5. Empagliflozin's Cardioprotective Role through Modulation of CCL2 Expression in Cardiac Fibroblasts, Attenuation of Inflammation, and Mitigation of Heart Failure Progression. (ポスター掲示,一般) 2024/03/10
全件表示(23件)